Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Hyaluronoglucosaminidase and Adrenocorticotropic Hormone

Research Papers that Mention the Interaction

The concept that adrenal steroids promote hyaluronidase activity stands in contrast to the impressive array of data compiled by other investigators which demonstrate that …, 1950; Seifter, Baeder and Begany, 1949), cortisone (Winter and Flataker, 1950; Seifter et al., 1950; Seifter, Baeder and Dervinis, 1949; Opsahl, 1949a) and ACTH (… hyaluronidase.
Endocrinology  •  1951  |  View Paper
Summary Anti-hyaluronidase agents , i.e. phosphorylated hesperidin, d-alphatocopherol phosphate, and chrondroitin sulfate were shown to be capable of increasing the effectiveness of administered pituitary trophic hormones such as follicle stimulating hormone (FSH) and corticotrophin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine  •  1953  |  View Paper
Coincidental anti-proteolytic action of these substances further enhanced such activity when the anti-hyaluronidase material together with the corticotrophin was injecte...
Recently (Cohen, et al., 1953) data were presented by the authors which demonstrated that anti-hyaluronidase agents are effective in delaying the absorption and in enhancing the activity of adrenocorticotrophin.
Endocrinology  •  1954  |  View Paper
ACTH given parenterally exhibited a significant antihyaluronidase effect.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine  •  1952  |  View Paper
4) In lymphocytic leukemia and Hodgkin's disease, cortisone, ACTH and other forms of therapy cause a decrease in the anti-hyaluronidase titre corresponding with clinical improvement. (
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine  •  1951  |  View Paper
Summary ACTH brings out a marked decrease in the level of the “nonspecific” hyaluronidase inhibitor in patients with rheumatic fever.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine  •  1950  |  View Paper